about
Discovery and validation of new potential biomarkers for early detection of colon cancerOrganochlorine exposure and colorectal cancer risk.Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancerVariability in prescription drug expenditures explained by adjusted clinical groups (ACG) case-mix: a cross-sectional study of patient electronic records in primary care.Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis.Large differences in global transcriptional regulatory programs of normal and tumor colon cellsClinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations.Telomere length and genetic anticipation in Lynch syndromeDietary flavonoids, lignans and colorectal cancer prognosis.Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal CancerGenetic variant in the telomerase gene modifies cancer risk in Lynch syndromeType 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain.Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer.Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study.Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectaTools for protein-protein interaction network analysis in cancer research.Polymorphisms within inflammatory genes and colorectal cancer.Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.Allele-specific expression of APC in adenomatous polyposis families.Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study).Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration.Evaluation of PAX3 genetic variants and nevus number.Participation rates in the selection of population controls in a case-control study of colorectal cancer using two recruitment methods.[Statistical analysis of genetic polymorphisms in epidemiological studies].SNPStats: a web tool for the analysis of association studies.A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA.SNPassoc: an R package to perform whole genome association studiesPolymorphisms in sulfotransferasesSULT1A1 andSULT1A2 are not related to colorectal cancerInterleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer riskPolymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal CancerColorectal cancer risk and theAPC D1822V variantClinicopathological risk factors of Stage II colon cancer: results of a prospective studyTumor Thymidylate Synthase 1494del6 Genotype As a Prognostic Factor in Colorectal Cancer Patients Receiving Fluorouracil-Based Adjuvant TreatmentDiet and K-ras mutations in colorectal cancerAssociation of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer
P50
Q21131953-62B927E6-2EDB-4BC0-97C6-79F5A822CB50Q24816092-0AA95AA6-B163-440D-B7C5-CF6F4C72C16FQ28168820-1637753C-F24B-4292-82EE-040F2C57D018Q33322405-995B5F1E-BC37-491C-859B-E945D064D093Q34081324-8C367AC9-53F1-49AD-B80F-666B5470E149Q34096808-EA84EB57-12A9-4540-87C9-ABF0BEACF700Q34278484-557D764D-2EFC-4DCE-8AD9-CFE07508F179Q34473636-EAD67E2F-EA7F-4253-84A4-62B0F7D7338CQ34479613-4516026F-E0CC-450C-85CB-CC71D0B559DDQ34588331-DFF184C0-778A-42DE-B034-9579A11A83BDQ34627905-14161364-0336-4D93-92E0-B9148F7C8F72Q34700165-B15EF20D-DC2B-4CDD-879B-8C1BF2318BAEQ36067927-374D37D1-9D0F-4BF6-B15A-7DDA32381C6FQ36172515-084BE054-1DE8-4D57-A5AD-CD2ECFA8829DQ36809661-2B969B63-53ED-43E8-92E7-0DA7DF1D77EDQ37314081-4DF9499B-67FB-4FE3-B287-DD0715634A13Q37548367-6D563F10-117C-4337-9ECE-EA18B86D4697Q37663150-D65850F3-5E74-43F6-8BD7-BC7E8A036C3DQ37802643-B0AB9DE4-47FB-4401-8CA0-F9DA21BB6994Q37977413-71845EF8-A485-4DCF-9352-8FEEBCF830D8Q39066122-DF0B5696-3D8C-4F05-B8F1-E0961E9E5D2FQ39682144-D1AF5CF8-893B-4319-8EBC-A79FCACC6BD2Q42115276-0C567964-7DC5-49CE-AACD-94F58DAD7500Q43882404-8262D772-4C99-4491-A8D3-4840E008BCA8Q43986380-029B969D-7933-4B3D-A18D-88A0F8374D42Q45366506-506A5857-9F70-40A1-85EB-C2E5FF4DDF52Q48127799-B491F6A1-5174-433E-A94F-02491EDD600DQ48708658-CFDDF1B9-B76F-4741-B40F-345361F7656FQ53731244-8AC4BF5C-606E-44E0-AD00-F9B4229008E3Q54740167-824A2AFE-165F-4C02-8C4F-14F75716622FQ57304600-21DA8C5F-4875-4775-AE93-820A70C85594Q57552180-3530D649-CAE2-48C7-8C0E-565B9BE5771FQ57610526-DE21568A-7945-4EFF-9E6B-253D23A8A1C2Q57610547-A809D823-E115-43C3-ABC5-55D8211A5C27Q57882344-DE79CC8C-DD87-45DA-A7A5-E08EFD4754ACQ58053589-7718E927-8817-485E-B22A-13A1231B70F4Q58053662-8AF4A859-1511-4307-B27A-BA81029F82B3Q58109887-407A3280-FB8D-425E-BE34-9630D743CE67Q61685466-46E072DA-DACB-4709-95EC-DA885A0AE918
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elisabet Guinó
@ast
Elisabet Guinó
@en
Elisabet Guinó
@es
Elisabet Guinó
@nl
type
label
Elisabet Guinó
@ast
Elisabet Guinó
@en
Elisabet Guinó
@es
Elisabet Guinó
@nl
prefLabel
Elisabet Guinó
@ast
Elisabet Guinó
@en
Elisabet Guinó
@es
Elisabet Guinó
@nl
P106
P31
P496
0000-0003-0093-2652